The blood-brain-barrier is both a vital defence and a formidable obstacle. It protects the brain from toxic substances that circulate in the blood, but limits the delivery of drugs that could be used ...

UPMC’s innovation, commercialization and venture capital arm plans to funnel a total of $1 billion into the development of new drugs, diagnostics and devices by 2024, the Pittsburgh-based health ...

SAN DIEGO, April 2, 2025 – Ascential Medical & Life Sciences, a leader in end-to-end solutions for complex medical and life science devices, today announced the release of its latest State of the ...

Texas’s premier life science conference returns to Houston in November, spotlighting breakthrough innovations in therapeutics, medical technology, and digital health. HOUSTON--(BUSINESS WIRE)--Rice ...

Taking a position in a life science exchange-traded fund (ETF) provides exposure to a basket of stocks focused on the healthcare sector, while mitigating the risks of holding shares in a single ...

William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas ...

Creating, launching and funding Life Sciences ventures is a difficult and daunting task, especially given recent market conditions. This course is a practical, hands-on field course primarily designed ...

PITTSBURGH--(BUSINESS WIRE)--Latticework Capital Management (“Latticework” or “LCM”), a growth oriented private equity firm focused on partnering with entrepreneurially-minded management teams to ...